NeoRad AS (NeoRad) is a privately-held medical device company, engaged in the design, development, manufacturing and marketing of devices used in the areas of radiology and interventional applications. Its devices are marketed through a network of distributors around the world. The company is headquartered in Oslo, Norway.

The company`s product SimpliCT is an interventional guidance device that utilizes a laser beam catered to enhance the accuracy of computed tomography (CT) guided puncture applications. Additionally, SimpliCT has the ability to boost the throughput of CT-guided puncture procedures such as biopsies and fluid drainage, and minimize patient discomfort. SimpliCT obtained marketing approval from the U.S. Food and Drug Administration (FDA), from the Kosheisho in Japan and a CE mark for marketing in Europe.

Further, its new product solutions are skin attachable ultrasound transducers with the potential to see inside the body and monitor various parameters. Through its research and development efforts, the company is developing a contrast media injection monitoring device and a breath sensor device.

Street: 
Parkveien 53B
City: 
Oslo
Postcode: 
0256
Federal State : 
Norway
WebSite: 
www.neorad.com
Fax: 
47-24-110951

Company Index Score

Current Index Score Historical Index Score
  • NeoRad AS currently scores 50 % in the index.
  • NeoRad AS is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • NeoRad AS is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets